Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria Immunity
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
This observational or N/A phase trial investigates Malaria, Falciparum and Plasmodium Falciparum and is currently completed. National Institute of Allergy and Infectious Diseases (NIAID) leads this study, which shows 15 recorded versions since 2010 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
15 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jan 2020 — Jan 2021 [monthly]
Completed
-
Dec 2019 — Jan 2020 [monthly]
Completed
▶ Show 10 earlier versions
-
Oct 2019 — Dec 2019 [monthly]
Completed
-
Sep 2019 — Oct 2019 [monthly]
Completed
-
May 2019 — Sep 2019 [monthly]
Completed
-
Mar 2019 — May 2019 [monthly]
Completed
-
Oct 2018 — Mar 2019 [monthly]
Completed
-
Sep 2018 — Oct 2018 [monthly]
Completed
-
Jun 2018 — Sep 2018 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Institute of Allergy and Infectious Diseases (NIAID)
For direct contact, visit the study record on ClinicalTrials.gov .